Brief: IRLAB Therapeutics Raises SEK 145 Mln Through Rights Issue

IRLAB Therapeutics AB

27/02/2020 08:35

Feb 27 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * IRLAB'S RIGHTS ISSUE OVERSUBSCRIBED
    * THROUGH RIGHTS ISSUE IRLAB WILL RECEIVE APPROXIMATELY SEK
145
MILLION BEFORE TRANSACTION COSTS

Source text for Eikon:  ID:nWkrbChW9q 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))